Karen L. Roberts
Corporate Officer/Principal at Massachusetts Biotechnology Council
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kendalle O'Connell | M | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | - |
Robert K. Coughlin | M | 55 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | - |
Mark O. Eisele | M | 66 |
The Financial Executives Institute
| - |
Kris Miller | M | 58 |
The Financial Executives Institute
| - |
Harry J. Cynkus | M | 74 |
The Financial Executives Institute
| - |
Geoffrey F. Cox | M | 80 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | - |
John J. Arcari | M | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.
The Financial Executives Institute
| - |
Ken Goldman | M | 74 |
The Financial Executives Institute
| - |
Abbie Celniker | M | 65 |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | - |
Allen Hagerman | M | 72 |
The Financial Executives Institute
| - |
Adrian D. Shelley | M | - |
The Financial Executives Institute
| - |
Joseph R. Maslick | M | - |
The Financial Executives Institute
| - |
Leon Hoffmann | M | - |
The Financial Executives Institute
| - |
Dan Amadori | M | 72 |
The Financial Executives Institute
| - |
Tom Lesnau | M | - |
The Financial Executives Institute
| - |
Robert Deslandes | M | - |
The Financial Executives Institute
| - |
Glen M. Johnson | M | 75 |
The Financial Executives Institute
| - |
George E. Aldrich | M | 77 |
The Financial Executives Institute
| - |
Jerome Walter Carlson | M | 87 |
The Financial Executives Institute
| - |
Alan Harris | M | 71 |
The Financial Executives Institute
| - |
Randall R. Simons | M | - |
The Financial Executives Institute
| - |
Russell C. Diehm | M | - |
The Financial Executives Institute
| - |
Margaret S. Poster | F | - |
The Financial Executives Institute
| - |
Kevin Phelps | M | 69 |
The Financial Executives Institute
| - |
David J. Blair | M | 70 |
The Financial Executives Institute
| - |
S. Bradford Rives | M | 65 |
The Financial Executives Institute
| - |
Vincent Rizzi | M | - |
The Financial Executives Institute
| - |
Murray Kay | M | - |
The Financial Executives Institute
| - |
Willard E. Imhoff | M | - |
The Financial Executives Institute
| - |
Robert Antoine | M | 67 |
The Financial Executives Institute
| - |
Mike Yukich | M | 78 |
The Financial Executives Institute
| - |
Gregory S. Motto | M | 51 |
The Financial Executives Institute
| - |
Leonard J. Gatti | M | - |
The Financial Executives Institute
| - |
John S. Doychich | M | - |
The Financial Executives Institute
| - |
Richard Bakewell | M | - |
The Financial Executives Institute
| - |
Margaret Cathy Douglas | F | 67 |
The Financial Executives Institute
| - |
John M. Varvaris | M | - |
The Financial Executives Institute
| - |
Russell Caso | M | - |
The Financial Executives Institute
| - |
Eileen Black | F | - |
The Financial Executives Institute
| - |
Brian K. Aitken | M | - |
The Financial Executives Institute
| - |
Duane Drake | M | - |
The Financial Executives Institute
| - |
Richard Peterson | M | 56 |
The Financial Executives Institute
| - |
Jerry A. Schneider | M | 76 |
The Financial Executives Institute
| - |
William R. A. Hogg | M | - |
The Financial Executives Institute
| - |
Kenneth Bodmer | M | - |
The Financial Executives Institute
| - |
Barry Belfer | M | - |
The Financial Executives Institute
| - |
Warren D. Fix | M | 85 |
The Financial Executives Institute
| - |
Anne L. Randall | F | - |
The Financial Executives Institute
| - |
David Hauser | M | 72 |
The Financial Executives Institute
| - |
John Daniel Gibbons | M | 71 |
The Financial Executives Institute
| - |
Philip A. Grybas | M | 76 |
The Financial Executives Institute
| - |
Christopher P. Johns | M | 63 |
The Financial Executives Institute
| - |
Joseph D'Agostino | M | 73 |
The Financial Executives Institute
| - |
Michael L. Hirons | M | 53 |
The Financial Executives Institute
| - |
Howard Yeaton | M | 69 |
The Financial Executives Institute
| - |
Laura Wright | F | 64 |
The Financial Executives Institute
| - |
Mark Foletta | M | 63 |
The Financial Executives Institute
| - |
Pamela D. Gormley | F | 75 |
The Financial Executives Institute
| - |
David Ricky Lowes | M | 69 |
The Financial Executives Institute
| - |
Stephen P. Dickson | M | 63 |
The Financial Executives Institute
| - |
Patrick T. Doyle | M | 68 |
The Financial Executives Institute
| - |
Anthony W. Ruggiero | M | 82 |
The Financial Executives Institute
| - |
Stephen F. Reeves | M | 64 |
The Financial Executives Institute
| - |
Regina Sommer | F | 66 |
The Financial Executives Institute
| - |
H. Eberhart | F | 70 |
The Financial Executives Institute
| - |
James T. Taylor | M | 77 |
The Financial Executives Institute
| - |
Dennis P. Himan | M | 79 |
The Financial Executives Institute
| - |
James W. Eldredge | M | 73 |
The Financial Executives Institute
| - |
Kenneth Clifford Kieley | M | 73 |
The Financial Executives Institute
| - |
Andrew J. Welch | M | 62 |
The Financial Executives Institute
| - |
James Schneider | M | 72 |
The Financial Executives Institute
| - |
William C. Stivers | M | 85 |
The Financial Executives Institute
| - |
Robert W. Goldman | M | 82 |
The Financial Executives Institute
| - |
Janet Haugen | F | 65 |
The Financial Executives Institute
| - |
Anthony Verdi | M | 75 |
The Financial Executives Institute
| - |
Trudy Rautio | F | 71 |
The Financial Executives Institute
| - |
Donovan D. Huennekens | M | 87 |
The Financial Executives Institute
| - |
T. Derek Price | M | - |
The Financial Executives Institute
| - |
Craig R. Ramsey | M | 73 |
The Financial Executives Institute
| - |
Thomas Kirk | M | 78 |
The Financial Executives Institute
| - |
Randy L. Pearce | M | 69 |
The Financial Executives Institute
| - |
Brian Finneran | M | 66 |
The Financial Executives Institute
| - |
Barbara A. Klein | F | 69 |
The Financial Executives Institute
| - |
Ray E. Dombrowski | M | - |
The Financial Executives Institute
| - |
Richard Reece | M | 68 |
The Financial Executives Institute
| - |
Richard M. Fowler | M | 81 |
The Financial Executives Institute
| - |
Michael E. Keane | M | 68 |
The Financial Executives Institute
| - |
Paul W. Hawran | M | 71 |
The Financial Executives Institute
| - |
Mark Prygocki | M | 58 |
The Financial Executives Institute
| - |
Jeffrey Wright | M | 61 |
The Financial Executives Institute
| - |
Dennis R. Wraase | M | 79 |
The Financial Executives Institute
| - |
Louis S. Massimo | M | 66 |
The Financial Executives Institute
| - |
Keith W. Smith | M | 89 |
The Financial Executives Institute
| - |
Jon Michael Lauer | M | 79 |
The Financial Executives Institute
| - |
Terrence E. Geremski | M | 76 |
The Financial Executives Institute
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher Guiffre | M | 56 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | - |
William Rastetter | M | 75 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | 3 years |
Paul Friedman | M | 81 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | 3 years |
Oliver Fetzer | M | 60 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | 5 years |
Ram Sasisekharan | M | 58 |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | 9 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karen L. Roberts
- Personal Network